Skip to main content
Clinical Trials/ACTRN12613000654752
ACTRN12613000654752
Completed
Phase 3

A Randomised Controlled Trial of Adults with Osteoarthritis treated with a Marinova Seaweed Extract compared to a Placebo measured by the Comprehensive Osteoarthritis Test (COAT).

Marinova Pty Ltd0 sites130 target enrollmentJune 14, 2013

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Marinova Pty Ltd
Enrollment
130
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Females and males, aged between 18 and 85 years.
  • X\-ray and clinical evidence of osteoarthritis of the knees.
  • In good general health.
  • Adequate venous access.
  • Female participants of childbearing age who agree to continue using birth control measures for the duration of the study.

Exclusion Criteria

  • A history of trauma associated with the affected joint.
  • Rheumatoid or other inflammatory joint conditions.
  • Individuals with thyroid disorder.
  • Individuals with diabetes.
  • Individuals taking Warfarin of other anti\-coagulant medication.
  • Participants with a VAS score above 7 at baseline.
  • Participants who have just commenced on a treatment regimen for arthritis.
  • Use of corticosteroids (intra\-articular or systematic) within 4 weeks prior to baseline and throughout the study.
  • Liver function tests greater than 3 times the upper limit of normal at baseline.
  • History of alcohol or substance abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials